MEDNAX, Inc. (MD) Tops Q1 EPS by 3c; Guides Q2 EPS
Tweet
Share
E-mailGet Alerts MD Hot Sheet
Join SI Premium – FREE
MEDNAX, Inc. (NYSE: MD) reported Q1 EPS of $0.94, $0.03 better than the analyst estimate of $0.91. Revenue for the quarter came in at $382.3 million versus the consensus estimate of $378.64 million.
Sees Q211 EPS of $1.11 - $1.17, versus the consensus of $1.16.
Sees Q211 EPS of $1.11 - $1.17, versus the consensus of $1.16.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- Ulta Beauty (ULTA) Tops Q1 EPS by 87c, Beats on Revenue; Offers FY27 EPS guidance
- Sprinklr (CXM) Tops Q1 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
